SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
(6‐((R)‐2‐{2‐[4‐(4‐Chloro‐phenoxy)‐piperidin‐1‐yl]‐ethyl}‐pyrrolidine‐1‐sulphonyl)‐1H‐indole hydrochloride) (SB‐656104‐A), a novel 5‐hydroxytryptamine (5‐HT 7) receptor antagonist, potently inhibited [3 H]‐SB‐269970 binding to the human cloned 5‐HT 7(a) (p Ki 8.7±0.1) and 5‐HT 7(b) (p Ki 8.5±0.2) receptor variants and the rat native receptor (p Ki 8.8±0.2). The compound displayed at least 30‐fold selectivity for the human 5‐HT 7(a) receptor versus other human cloned 5‐HT receptors apart from the 5‐HT 1D receptor (∼10‐fold selective). SB‐656104‐A antagonised competitively the 5‐carboxamidotryptamine (5‐CT)‐induced accumulation of cyclic AMP in h5‐HT 7(a)/HEK293 cells with a pA 2 of 8.5. Following a constant rate iv infusion to steady state in rats, SB‐656104 had a blood clearance (CL b) of 58±6 ml min−1 kg−1 and was CNS penetrant with a steady‐state brain : blood ratio of 0.9 : 1. Following i.p. administration to rats (10 mg kg−1), the compound displayed a t1/2 of 1.4 h with mean brain and blood concentrations (at 1 h after dosing) of 0.80 and 1.0 μM, respectively. SB‐656104‐A produced a significant reversal of the 5‐CT‐induced hypothermic effect in guinea pigs, a pharmacodynamic model of 5‐HT 7 receptor interaction in vivo (ED 50 2 mg kg−1). SB‐656104‐A, administered to rats at the beginning of the sleep period (CT 0), significantly increased the latency to onset of rapid eye movement (REM) sleep at 30 mg kg−1 i.p. (+93%) and reduced the total amount of REM sleep at 10 and 30 mg kg−1 i.p. with no significant effect on the latency to, or amount of, non‐REM sleep. SB‐269970‐A produced qualitatively similar effects in the same study. In summary, SB‐656104‐A is a novel 5‐HT 7 receptor antagonist which has been utilised in the present study to provide further evidence for a role for 5‐HT 7 receptors in the modulation of REM sleep. British Journal of Pharmacology (2003) 139, 705–714. doi:10.1038/sj.bjp.0705290
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Dijk, D., & Czeisler, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03526.1995 · Cited by 1,356 · cited 2×
“Furthermore, modulation of circadian phase has been shown to alter a number of sleep parameters, including REM sleep (Dijk & Czeisler, 1995).”
BackgroundThe Neurobiology of Sleep: Genetics, cellular physiology and subcortical networks
Pace-Schott, E. F., & Hobson, J. A. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn895 · Cited by 937 · cited 2×
“…also in a number of other brain areas, namely, the dorsal raphe nucleus (Roberts et al., 2001), thalamus (Chapin & Andrade, 2001) and hippocampal CA3 region (Bacon & Beck, 2001; Gill et al., 2002), which have all been implicated in sleep and/or circadian rhythm control (Pace-Schott & Hobson, 2002).”
BackgroundIn Vivo Resetting of the Hamster Circadian Clock by 5-HT7Receptors in the Suprachiasmatic Nucleus
Ehlen, J. C., Grossman, G. H., & Glass, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05351.2001 · Cited by 139
Effect of bupropion-SR on REM sleep: relationship to antidepressant response
Ott, G., Rao, U., Nuccio, I., Lin, K.-M., & Poland, R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1165-4 · Cited by 34
Cited by
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The Roles of Serotonin in Neuropsychiatric Disorders
Pourhamzeh, M., Moravej, F. G., Arabi, M., Shahriari, E., Mehrabi, S., Ward, R., Ahadi, R., & Joghataei, M. T. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01064-9 · Cited by 366
Functional, molecular and pharmacological advances in 5-HT receptor research
HEDLUND, P., & SUTCLIFFE, J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.002 · Cited by 350
The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking
MONTI, J., & JANTOS, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00929-1 · Cited by 302
Metadata
- Authors
- Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P., Stevens, A. J., Deeks, N. J., Eddershaw, P. J., Fenwick, S. H., Riley, G., Stean, T., Scott, C. M., Hill, M. J., Middlemiss, D. N., Hagan, J. J., Price, G. W., & Forbes, I. T.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2003-06
- Volume
- 139
- Issue
- 4
- Pages
- 705-714
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2048995786
- Cited by
- 127
- References
- 5
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats. https://app.cochat.ai/papers/10.1038/sj.bjp.0705290
- The paper
- Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P., Stevens, A. J., Deeks, N. J., Eddershaw, P. J., Fenwick, S. H., Riley, G., Stean, T., Scott, C. M., Hill, M. J., Middlemiss, D. N., Hagan, J. J., Price, G. W., & Forbes, I. T. (2003). SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705290
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.